Nektar Therapeutics
NASDAQ:NKTRBiotechnology
Healthcare
$32.54 -2.04%
-$1.24 today
- Market cap
- $933.51M
- Beta
- 1.15
- P/E (TTM)
- -9.3
- EPS (TTM)
- -$6.39
52W Low $8.27High $109.00
Volume 0.86M
Average 1.00M
Price history
Nektar Therapeutics SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-46.08%
Period high
$100.35
Period low
$32.54
Latest
$32.54
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 13, 2026 | Nov 12, 2026 | |
| 8-K | Nov 13, 2026 | Nov 13, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| S-8 | Oct 20, 2026 | Oct 19, 2026 | |
| 8-K | Oct 1, 2026 | Oct 1, 2026 | |
| SC 13G/A | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 8-K | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 8-K | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 |
Competitors
Who does Nektar Therapeutics compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about NKTR's filings, answered from its disclosures.
What is the latest NKTR filing?
The latest filing shown is 10-Q dated Nov 13, 2026.
How many recent filings does NKTR have?
Intrinsic Alpha currently shows 20 recent filings for NKTR.
Continue the stock analysis
Jump to another research area for this company.